Krain RL - Search Results

1

Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus.

Chakka S, Krain RL, Ahmed S, Concha JSS, Feng R, Merrill JT, Werth VP. Chakka S, et al. Among authors: krain rl. J Am Acad Dermatol. 2021 Jun;84(6):1562-1567. doi: 10.1016/j.jaad.2020.07.047. Epub 2020 Jul 16. J Am Acad Dermatol. 2021. PMID: 32682879 Free PMC article.

2

Diagnosing muscle disease in a cohort of classic dermatomyositis patients seen at a rheumatologic dermatology outpatient clinic.

Ahmed S, Concha JSS, Chakka S, Krain RL, Zamalin D, Foulke G, Werth VP. Ahmed S, et al. Among authors: krain rl. J Am Acad Dermatol. 2022 Mar;86(3):544-550. doi: 10.1016/j.jaad.2021.05.026. Epub 2021 May 26. J Am Acad Dermatol. 2022. PMID: 34051316

3

Cutaneous lupus concerns from the patient perspective: a qualitative study.

Yan D, Zamalin D, Chakka S, Krain R, Concha J, Feng R, Ahmed S, Okawa J, Werth VP. Yan D, et al. Lupus Sci Med. 2021 Aug;8(1):e000444. doi: 10.1136/lupus-2020-000444. Lupus Sci Med. 2021. PMID: 34452954 Free PMC article.

4

Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area Index.

Krain RL, Bax CE, Chakka S, Ahmed S, Feng R, Payne AS, Werth VP. Krain RL, et al. Br J Dermatol. 2021 May;184(5):975-977. doi: 10.1111/bjd.19718. Epub 2021 Feb 1. Br J Dermatol. 2021. PMID: 33314027 Free PMC article. No abstract available.

5

Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis.

Ahmed S, Chakka S, Concha J, Krain R, Feng R, Werth VP. Ahmed S, et al. Br J Dermatol. 2020 Apr;182(4):949-954. doi: 10.1111/bjd.18223. Epub 2019 Sep 8. Br J Dermatol. 2020. PMID: 31206600 Free PMC article.

6

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.

Chen KL, Krain RL, Werth VP. Chen KL, et al. Among authors: krain rl. F1000Res. 2019 Mar 25;8:F1000 Faculty Rev-332. doi: 10.12688/f1000research.17787.1. eCollection 2019. F1000Res. 2019. PMID: 30984372 Free PMC article. Review.

7

Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.

Krain RL, Kushner CJ, Tarazi M, Gaffney RG, Yeguez AC, Zamalin DE, Pearson DR, Feng R, Payne AS, Werth VP. Krain RL, et al. Front Immunol. 2019 Nov 6;10:2571. doi: 10.3389/fimmu.2019.02571. eCollection 2019. Front Immunol. 2019. PMID: 31781098 Free PMC article.

8

A prospective cohort study comparing the performance of interferon gamma release assays in autoimmune skin diseases.

Yan D, Gaffney R, Krain R, Keyes E, Concha JS, Feng R, Schulz S, Pappas-Taffer L, Borucki R, Ravishankar A, Bax C, Okawa J, Werth VP. Yan D, et al. J Am Acad Dermatol. 2022 Apr;86(4):948-949. doi: 10.1016/j.jaad.2021.03.087. Epub 2021 Apr 2. J Am Acad Dermatol. 2022. PMID: 33812955 No abstract available.

9

Management of autoimmune blistering diseases in pregnancy and the neonate.

Krain RL, Chen KL, Werth VP. Krain RL, et al. G Ital Dermatol Venereol. 2019 Oct;154(5):539-549. doi: 10.23736/S0392-0488.19.06375-2. Epub 2019 Jun 12. G Ital Dermatol Venereol. 2019. PMID: 31195784 Review.

10

The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.

Chakka S, Krain RL, Concha JSS, Chong BF, Merola JF, Werth VP. Chakka S, et al. Among authors: krain rl. Ann Transl Med. 2021 Mar;9(5):431. doi: 10.21037/atm-20-5048. Ann Transl Med. 2021. PMID: 33842652 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters